Adverum Biotechnologies
ADVM
ADVM
94 hedge funds and large institutions have $549M invested in Adverum Biotechnologies in 2019 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 13 closing their positions.
Holders
94
Holders Change
+11
Holders Change %
+13.25%
% of All Funds
2.04%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
27
Increased
29
Reduced
23
Closed
13
Calls
$1.24M
Puts
$869K
Net Calls
+$373K
Net Calls Change
+$183K
Top Buyers
| 1 |
ACA
1
Avoro Capital Advisors
New York
|
$41.6M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$37.3M |
| 3 |
O
3
OrbiMed
New York
|
$23.3M |
| 4 |
PC
4
Polar Capital
London,
United Kingdom
|
$7.45M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$18M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Man Group
London,
United Kingdom
| – | – | -3,851 | Closed |
|
102
Principal Financial Group
Des Moines,
Iowa
| – | – | -2,202 | Closed |
|
|
DS
103
DRW Securities
Chicago,
Illinois
| – | – | -2,010 | Closed |
|
|
ARTA
104
A.R.T. Advisors
New York
| – | – | -1,737 | Closed |
|
105
SG Americas Securities
New York
| – | – | -1,136 | Closed |
|
|
CHP
106
Cable Hill Partners
Portland,
Oregon
| – | – | -250 | Closed |
|
|
TRCT
107
Tower Research Capital (TRC)
New York
| – | – | -175 | Closed |
|
|
CFGS
108
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|